Gaetano Maria De Ferrari

1987–2025 年に発表

別表記
Gaetano Maria de Ferrari
241
論文数
27,523
被引用数
71
h 指数
210
i10 指数

被引用数

Gaetano Maria De Ferrari の年別被引用数1976 年: 被引用 1 件1985 年: 被引用 1 件1988 年: 被引用 4 件1989 年: 被引用 2 件1990 年: 被引用 3 件1991 年: 被引用 10 件1992 年: 被引用 12 件1993 年: 被引用 15 件1994 年: 被引用 10 件1995 年: 被引用 21 件1996 年: 被引用 23 件1997 年: 被引用 16 件1998 年: 被引用 24 件1999 年: 被引用 15 件2000 年: 被引用 18 件2001 年: 被引用 15 件2002 年: 被引用 27 件2003 年: 被引用 20 件2004 年: 被引用 15 件2005 年: 被引用 29 件2006 年: 被引用 44 件2007 年: 被引用 30 件2008 年: 被引用 74 件2009 年: 被引用 58 件2010 年: 被引用 72 件2011 年: 被引用 74 件2012 年: 被引用 79 件2013 年: 被引用 90 件2014 年: 被引用 107 件2015 年: 被引用 118 件2016 年: 被引用 188 件2017 年: 被引用 201 件2018 年: 被引用 185 件2019 年: 被引用 629 件2020 年: 被引用 1,027 件2021 年: 被引用 1,022 件2022 年: 被引用 772 件2023 年: 被引用 632 件2024 年: 被引用 1,398 件2025 年: 被引用 746 件2026 年: 被引用 65 件2027 年: 被引用 1 件1977〜1984 年は被引用が無いため表示していません1986〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,541 件、この内訳の 19.4%イタリア: 引用元論文 1,426 件、この内訳の 10.9%イギリス: 引用元論文 983 件、この内訳の 7.5%ドイツ: 引用元論文 699 件、この内訳の 5.3%中国: 引用元論文 639 件、この内訳の 4.9%オランダ: 引用元論文 526 件、この内訳の 4%カナダ: 引用元論文 473 件、この内訳の 3.6%フランス: 引用元論文 437 件、この内訳の 3.3%スペイン: 引用元論文 429 件、この内訳の 3.3%オーストラリア: 引用元論文 374 件、この内訳の 2.8%スイス: 引用元論文 314 件、この内訳の 2.4%日本: 引用元論文 314 件、この内訳の 2.4%
0%19.4%その他 30.2%

分野

  • Medicine81.7%
  • Biochemistry, Genetics and Molecular Biology7%
  • Neuroscience4.9%
  • Engineering2%
  • Immunology and Microbiology1.2%
  • Health Professions0.6%
  • その他2.6%

トピック

  • Lipoproteins and Cardiovascular Health7%
  • Cardiac electrophysiology and arrhythmias4.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.2%
  • Heart Rate Variability and Autonomic Control3.1%
  • COVID-19 and healthcare impacts2.6%
  • Acute Myocardial Infarction Research2.5%
  • その他77.2%

共著者

全論文

検索で開く
  1. 2023 ESC Guidelines for the management of cardiomyopathies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Magdy Abdelhamid, Victor Aboyans, Michael Arad, Folkert W. Asselbergs, Riccardo Asteggiano, Zofia T. Bilińska, Damien Bonnet, Henning Bundgaard, Nuno Cardim, Jelena Čelutkienė, Maja Čikeš, Gaetano Maria De Ferrari, Veronica Dusi, Volkmar Falk, Laurent Fauchier, Estelle Gandjbakhch, Tiina Heliö, Konstantinos C. Koskinas, Dipak Kotecha, Ulf Landmesser, George Lazaros, Basil S. Lewis, Aleš Linhart, Maja‐Lisa Løchen, Benjamin Meder, Richard Mindham, James Moon, Jens Cosedis Nielsen, Steffen E. Petersen, Eva Prescott, Mary N. Sheppard, Gianfranco Sinagra, Marta Sitges, Jacob Tfelt‐Hansen, Rhian M. Touyz, Rogier J. A. Veltrop, Josef Veselka, Karim Wahbi, Arthur A.M. Wilde, Katja Zeppenfeld, B. Kichou, Hamayak Sisakian, Daniel Scherr, Bernhard Gerber, Alen Džubur, Мариана Господинова, Ivo Planinc, Hera Heracleous Moustra, David Zemánek, Morten K. Jensen, Ahmad Samir, Kairit Palm, Tiina Heliö, Karim Wahbi, Eric Schulze‐Bahr, Vlachopoulos Haralambos, Róbert Sepp, Berglind Aðalsteinsdóttir, Deirdre Ward, Miry Blich, Gianfranco Sinagra, Afrim Poniku, Olga Lunegova, Ainārs Rudzītis, Roland Kassab, Jūratė Barysienė, Steve Huijnen, Tiziana Felice, Eleonora Vataman, Nikola Pavlović ほか 41 名 - European Heart Journal 2023 被引用: 2,384

  2. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 4,415

  3. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Enrico Cerrato, Ferdinando Varbella, Michela Sperti, Stephen B. Wilton, Lazar Velicki, Ioanna Xanthopoulou, Ángel Cequier, Andrés Íñiguez, Isabel Muñoz Pousa, M Cespon Fernandez, Berenice Caneiro Queija, Rafael Cobas Paz, Ángel López‐Cuenca, Alberto Garay, Pedro Flores Blanco, Andrea Rognoni, Giuseppe Biondi‐Zoccai, Simone Biscaglia, Iván J. Núñez‐Gil, Toshiharu Fujii, Alessandro Durante, Xiantao Song, Tetsuma Kawaji, Dimitrios Alexopoulos, Zenon Huczek, José Ramón González‐Juanatey, Shaoping Nie, Masa‐aki Kawashiri, Iacopo Colonnelli, Barbara Cantalupo, Roberto Esposito, Sergio Leonardi, Walter Grosso Marra, Alaide Chieffo, Umberto Michelucci, Dario Piga, Marta Malavolta, Sebastiano Gili, Marco Mennuni, Claudio Montalto, Luigi Oltrona Visconti, Yasir Arfat - The Lancet 2021 被引用: 334

  4. Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2017 被引用: 677

  5. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial

    著者: , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2017 被引用: 596

  6. Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erik Cura-Stura, Mauro Rinaldi, Gaetano Maria De Ferrari, Antonella Fava, Elena Maria Richiardi, Jelena Celutkiene, Marta Filipova, Joanna Ciosek, Michal Guzy, Radoslaw Kurzelowski, Wojtek Wojakowski, Marija Bjelobrk, Aleksandra Ilic, Mila Kovacevic, Tatjana Miljkovic, Andrej Preveden, Ilija Srdanovic, Srdjan Aleksandric, Milika Asanin, Branko Beleslin, Milica Bojanic, Nikola Boskovic, Sladjana Bosic, Natasa Cvetinovic, Vladimir Dedovic, Vojislav Giga, Predrag Jandric, Milena Jaukovic, Miodrag Jovanovic, Ana Kovacevic-Kuzmanovic, Goran Loncar, Andrea Manojlovic, Milos Matkovic, Predrag Mitrovic, Ivana Nedeljkovic, Milan Nedeljkovic, Olgica Petrovic, Arsen Ristic, Mirjana Seper, Dragan Simic, Sanja Stankovic, Sinisa Stojkovic, Vladan Vukcevic, Katarina Zivic - Circulation 2021 被引用: 282

  7. Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE

    著者: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2023 被引用: 173

  8. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial

    著者: , , , , , , , , , , , , , , , , , , , - European Heart Journal 2014 被引用: 374

  9. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Brucato, Yehuda Adler - European Journal of Preventive Cardiology 2019 被引用: 182

  10. Clinical neurocardiology defining the value of neuroscience‐based cardiovascular therapeutics

    著者: , , , , , , , , , , , , , , , , , , , , - The Journal of Physiology 2016 被引用: 314

  11. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease

    著者: , , , , , , , , , , , , , - Circulation 2018 被引用: 256

  12. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure

    著者: , , , , , , , , , , , , , - European Heart Journal 2010 被引用: 520

  13. Current and Future Applications of Computational Fluid Dynamics in Coronary Artery Disease

    著者: , , , , , , , - Reviews in Cardiovascular Medicine 2022 被引用: 64

  14. Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol

    著者: , , , , , , , , , - JAMA Cardiology 2017 被引用: 203

  15. Right Ventricular–Pulmonary Arterial Coupling in Secondary Tricuspid Regurgitation

    著者: , , , , , , , , - The American Journal of Cardiology 2021 被引用: 128

  16. Coronary Plaque Characteristics Associated With Major Adverse Cardiovascular Events in Atherosclerotic Patients and Lesions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JACC. Cardiovascular imaging 2023 被引用: 100

  17. Asymptomatic Patients With Brugada ECG Pattern: Long-Term Prognosis From a Large Prospective Study

    著者: , , , , , , , , , , , , , , , , , , , , - Circulation 2023 被引用: 66

  18. Differences Between Cardiogenic Shock Related to Acute Decompensated Heart Failure and Acute Myocardial Infarction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guido Tavazzi - ESC Heart Failure 2023 被引用: 58

  19. Cardiovascular disease burden: Italian and global perspectives

    著者: , , , , , , - Minerva Cardiology and Angiology 2021 被引用: 90

  20. Electrical storm treatment by percutaneous stellate ganglion block: the STAR study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vito Sgromo, Gaetano Maria De Ferrari, the STAR study group, Alessandro Fasolino, Sara Bendotti, Roberto Primi, Angelo Auricchio, Giulio Conte, Pietro Rossi, Filippo Angelini, Arianna Morena, António Toscano, Valeria Carinci, Giuseppe Dattilo, Nastasia Mancini, Marco Corda, Gianfranco Tola, G Binaghi, Claudia Scudu, Lucy Barone, Alessandro Lupi, Claudia Carassia, Federica De Vecchi, Sara Vargiu - European Heart Journal 2024 被引用: 83

  21. Digoxin and Mortality in Patients With Atrial Fibrillation

    著者: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 被引用: 213

  22. Long-term vagal stimulation for heart failure: Eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial

    著者: , , , , , , , , , , , , , , , , , , - International Journal of Cardiology 2017 被引用: 154

  23. Left Cardiac Sympathetic Denervation for Long QT Syndrome

    著者: , , , , , , , , , , , , - JACC. Clinical electrophysiology 2021 被引用: 71

  24. SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock‐2 registry

    著者: , , , , , , , , , , , , , , , , , - Catheterization and Cardiovascular Interventions 2022 被引用: 55